14 days of Premium, free.
Every scanner with live hit rates + the Market Pulse risk flag that tells you when to get defensive. No card required.
Start trial →
Tradestie Institutional Equity Comparison Engine · Market Close Nov 16, 2026
MYGN vs QLTI: Which Stock Is the Better Buy Now?
Deterministic 6-pillar institutional evaluation across valuation multiples, TTM & multi-year operating margins, cash generation, options IV skew, and supply-chain moat.
As of Nov 16, 2026, Myriad Genetics Inc (MYGN) is the stronger overall head-to-head candidate over GMO International Quality ETF (QLTI) in the Tradestie Institutional Equity Comparison Engine, winning 7–3 core matrix metrics and 6–0 across our 6-pillar institutional scorecard (led by Valuation Multiples, Growth & Scale, Profitability & Quality). MYGN carries a Unified Composite Score of 46.2/100 (HOLD) at $5.57 (54.0x Forward P/E, -13.3% operating margin), whereas QLTI carries 47.8/100 (HOLD) at $28.11 (N/M Forward P/E, N/A operating margin).
Composite vs. Pillar Nuance: While QLTI currently prints a higher short-term Unified Composite Score (47.8/100 HOLD vs. MYGN 46.2/100 HOLD), MYGN captures the overall institutional head-to-head verdict (7–3 matrix metrics and 6–0 across the 6 pillars) due to superior fundamental profitability (-13.3% vs. N/A operating margin) and revenue trajectory (-1.5% vs. N/A YoY).
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on MYGN vs QLTI. Trailing 12-month operating profitability (MYGN -13.3% vs QLTI N/A) and valuation multiples (MYGN 54.0x vs QLTI N/M Forward P/E) are benchmarked directly in Pillar 4 below.
Competes within the Institutional Equity value chain with N/A market capitalization and N/A operating margin.
OpEx & R&D ReinvestmentN/A
90D Engineering Disclosures0 Published
Investor FAQ MYGN vs QLTI Key Questions & Quantitative Answers
As of Nov 16, 2026, Myriad Genetics Inc (MYGN) is the stronger overall head-to-head candidate over GMO International Quality ETF (QLTI) in the Tradestie Institutional Equity Comparison Engine, winning 7–3 core matrix metrics and 6–0 across our 6-pillar institutional scorecard (led by Valuation Multiples, Growth & Scale, Profitability & Quality). MYGN carries a Unified Composite Score of 46.2/100 (HOLD) at $5.57 (54.0x Forward P/E, -13.3% operating margin), whereas QLTI carries 47.8/100 (HOLD) at $28.11 (N/M Forward P/E, N/A operating margin). Composite vs. Pillar Nuance: While QLTI currently prints a higher short-term Unified Composite Score (47.8/100 HOLD vs. MYGN 46.2/100 HOLD), MYGN captures the overall institutional head-to-head verdict (7–3 matrix metrics and 6–0 across the 6 pillars) due to superior fundamental profitability (-13.3% vs. N/A operating margin) and revenue trajectory (-1.5% vs. N/A YoY).
MYGN leads the Growth & Scale pillar: MYGN posts -1.5% YoY revenue growth and +0.0% YoY earnings growth on $804M TTM revenue (68.3% gross margin, -13.3% operating margin), compared with QLTI at N/A YoY revenue growth and N/A YoY earnings growth on N/A TTM revenue (N/A gross margin, N/A operating margin). On trailing 12-month operating scale, MYGN generates $804M in USD-normalized revenue versus N/A for QLTI. In operating R&D and SG&A reinvestment, MYGN deploys 81.6% of Rev ($656M) (0 90-day corporate R&D disclosures) versus N/A (0 disclosures) for QLTI.
MYGN screens cheaper on headline valuation multiples. MYGN trades at 54.0x Forward P/E, 54.0x Trailing P/E, 1.40x PEG, and 0.8x EV/Revenue (-4.7% FCF margin), whereas QLTI trades at N/M Forward P/E, N/M Trailing P/E, N/M PEG, and N/M EV/Revenue (unreported cash flow margin). Multiples above 150x or negative earnings denominators are marked N/M to avoid distorted accounting comparisons; weigh lower Forward P/E and PEG against MYGN (-40.2% ROE) versus QLTI (N/A ROE) capital efficiency.
In options market volatility and institutional positioning, MYGN carries 124.6% implied volatility (22nd %ile, Compressed (<25th %ile)), unclassified Put/Call open interest, DISTRIBUTION on-balance volume, and sits in a SURGE options structure phase (0.68β · 122% Vol realized risk). By comparison, QLTI carries N/A implied volatility (N/A, Unclassified), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (0.81β · 16% Vol realized risk).
Cross-Compare 1-Click Peer Rivalries & Single-Stock Research
Powered by Tradestie Institutional Equity Comparison Engine & standardized corporate financial telemetry. Market close as of Nov 16, 2026. For educational research only; not investment advice.